All News IDEXX Laboratories, Inc.

Equities

IDXX

US45168D1046

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
497 ^USD	-0.56%		-3.79%	-10.47%

May. 29	Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 10:55 AM
May. 14	Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 10:55 AM	May. 29
IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day	May. 14	BU
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620	May. 14	MT
BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653	May. 02	MT
Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675	May. 02	MT
Stifel Adjusts Price Target on IDEXX Laboratories to $520 From $570	May. 02	MT
Barclays Adjusts Price Target on IDEXX Laboratories to $570 From $655	May. 02	MT
Redburn Atlantic Adjusts Price Target on IDEXX Laboratories to $500 From $460	May. 02	MT
IDEXX Laboratories : Q1 2024 Earnings Snapshot	May. 02	PU
Wall Street: heaviness prevails after a volatile episode	May. 01	CF
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.	May. 01	CI
IDEXX Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01	CI
Transcript : IDEXX Laboratories, Inc., Q1 2024 Earnings Call, May 01, 2024	May. 01
IDEXX Laboratories' Q1 Earnings, Revenue Increase	May. 01	MT
Earnings Flash (IDXX) IDEXX LABORATORIES Posts Q1 Revenue $964.1M, vs. Street Est of $965.8M	May. 01	MT
Idexx: Q1 Earnings Snapshot	May. 01	AQ
IDEXX Laboratories Announces First Quarter Results	May. 01	BU
Idexx Laboratories, Inc. Revises Earnings Guidance for 2024	May. 01	CI
North American Morning Briefing : Traders Wait for -2-	May. 01	DJ
BofA Securities Cuts Price Target on IDEXX Laboratories to $595 From $600, Maintains Neutral Rating	Apr. 30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Idexx Laboratories: Superior growth prospects

March 11, 2024 at 01:18 pm EDT